期刊文献+

Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity 被引量:7

Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity
下载PDF
导出
摘要 Hepatitis B virus(HBV)chronically infects more than350 million people worldwide.HBV causes acute and chronic hepatitis,and is one of the major causes of cirrhosis and hepatocellular carcinoma.There exist complex interactions between HBV and the immune system including adaptive and innate immunity.Tolllike receptors(TLRs)and TLR-signaling pathways are important parts of the innate immune response in HBV infections.It is well known that TLR-ligands could suppress HBV replication and that TLRs play important roles in anti-viral defense.Previous immunological studies demonstrated that HBV e antigen(HBeAg)is more efficient at eliciting T-cell tolerance,including production of specific cytokines IL-2 and interferon gamma,than HBV core antigen.HBeAg downregulates cytokine production in hepatocytes by the inhibition of MAPK or NF-κB activation through the interaction with receptor-interacting serine/threonine protein kinase.MicroRNAs(miRNAs)are also able to regulate various biological processes such as the innate immune response.When the expressions of approximately 1000 miRNAs were compared between human hepatoma cells HepG2 and HepG2.2.15,which could produce HBV virion that infects chimpanzees,using real-time RT-PCR,we observed several different expression levels in miRNAs related to TLRs.Although we and others have shown that HBV modulates the host immune response,several of the miRNAs seem to be involved in the TLR signaling pathways.The possibility that alteration of these miRNAs during HBV infection might play a critical role in innate immunity against HBV infection should be considered.This article is intended to comprehensively review the association between HBV and innate immunity,and to discuss the role of miRNAs in the innate immune response to HBV infection. Hepatitis B virus(HBV) chronically infects more than 350 million people worldwide.HBV causes acute and chronic hepatitis,and is one of the major causes of cirrhosis and hepatocellular carcinoma.There exist complex interactions between HBV and the immune system including adaptive and innate immunity.Tolllike receptors(TLRs) and TLR-signaling pathways are important parts of the innate immune response in HBV infections.It is well known that TLR-ligands could suppress HBV replication and that TLRs play important roles in anti-viral defense.Previous immunological studies demonstrated that HBV e antigen(HBeAg) is more efficient at eliciting T-cell tolerance,including production of specific cytokines IL-2 and interferon gamma,than HBV core antigen.HBeAg downregulates cytokine production in hepatocytes by the inhibition of MAPK or NF-κB activation through the interaction with receptor-interacting serine/threonine protein kinase.MicroRNAs(miRNAs) are also able to regulate various biological processes such as the innate immune response.When the expressions of approximately 1000 miRNAs were compared between human hepatoma cells HepG2 and HepG2.2.15,which could produce HBV virion that infects chimpanzees,using real-time RT-PCR,we observed several different expression levels in miRNAs related to TLRs.Although we and others have shown that HBV modulates the host immune response,several of the miRNAs seem to be involved in the TLR signaling pathways.The possibility that alteration of these miRNAs during HBV infection might play a critical role in innate immunity against HBV infection should be considered.This article is intended to comprehensively review the association between HBV and innate immunity,and to discuss the role of miRNAs in the innate immune response to HBV infection.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第23期7197-7206,共10页 世界胃肠病学杂志(英文版)
基金 Supported by Grants for"Asia-Oceania Collaborative Research Grants"from Kanae Foundation for the Promotion of Medical Science(to Kanda T) Grants for Scientific Research from the Ministry of Education,Culture,Sports,Science,and Technology,Japan(to Kanda T)
关键词 Hepatitis B virus HEPG2.2.15 Innate immunity MICRORNA Persistent infection Toll-like receptor Hepatitis B virus HepG2.2.15 Innate immunity Micro
  • 相关文献

参考文献20

  • 1Jae Youn Cheong,Hyoung Doo Shin,Yoon Jun Kim,Sung Won Cho.Association of polymorphism in MicroRNA 219‐1 with clearance of hepatitis B virus infection[J]. J. Med. Virol. . 2013 (5)
  • 2Keiko Arataki,C. Nelson Hayes,Sakura Akamatsu,Rie Akiyama,Hiromi Abe,Masataka Tsuge,Daiki Miki,Hidenori Ochi,Nobuhiko Hiraga,Michio Imamura,Shoichi Takahashi,Hiroshi Aikata,Tomokazu Kawaoka,Hiroiku Kawakami,Waka Ohishi,Kazuaki Chayama.Circulating microRNA‐22 correlates with microRNA‐122 and represents viral replication and liver injury in patients with chronic hepatitis B[J]. J. Med. Virol. . 2013 (5)
  • 3Joydip Bhanja Chowdhury,Shubham Shrivastava,Robert Steele,Adrian M. Di Bisceglie,Ranjit Ray,Ratna B. Ray.Hepatitis C Virus Infection Modulates Expression of Interferon Stimulatory Gene IFITM1 by Upregulating miR-130A[J]. Journal of Virology . 2012 (18)
  • 4Hashem B. El-Serag.Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma[J]. Gastroenterology . 2012 (6)
  • 5Mamoru Satoh,Tsuyoshi Tabuchi,Yoshitaka Minami,Yuji Takahashi,Tomonori Itoh,Motoyuki Nakamura.Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: Effect of statins on let-7i and Toll-like receptor 4 signal[J]. Immunobiology . 2011 (5)
  • 6Taro Kawai,Shizuo Akira.Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity[J].Immunity.2011(5)
  • 7Tali Lang,Camden Lo,Narelle Skinner,Stephen Locarnini,Kumar Visvanathan,Ashley Mansell.The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway[J]. Journal of Hepatology . 2011 (4)
  • 8Wan-Hsin Liu,Shiou-Hwei Yeh,Pei-Jer Chen.Role of microRNAs in hepatitis B virus replication and pathogenesis[J]. BBA - Gene Regulatory Mechanisms . 2011 (11)
  • 9Takeshi Tanaka,Makoto Arai,Shuang Wu,Tatsuo Kanda,Hideaki Miyauchi,Fumio Imazeki,Hisahiro Matsubara,Osamu Yokosuka.Epigenetic silencing of microRNA-373 plays an important role in regulatingcell proliferation in colon cancer[J]. Oncology Reports . 2011 (5)
  • 10Shuang Wu,Tatsuo Kanda,Fumio Imazeki,Shingo Nakamoto,Hiroshi Shirasawa,Osamu Yokosuka.Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines[J]. Cancer Letters . 2011 (1)

共引文献36

同被引文献114

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部